Assiut University: Lung Diseases, Interstitial trials
The registry lists 20 Lung Diseases, Interstitial studies with Assiut University as lead sponsor. 10 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 2No phase 18(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Combined Growth Differentiation Factor-15 (GDF-15) and Lung Ultrasound for ILD Screening in Rheumatoid Arthritis and Systemic SclerosisNot yet recruitingNCT07839221
- Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening SymptomsNot yet recruitingNCT07728448
- Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis PatientsNot yet recruitingNCT07003451
- Non-Invasive Hemodynamic Monitoring of MV ILD Patients With ARFNot yet recruitingNCT06927089
- Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)Not yet recruitingNCT06615128
- Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.Not yet recruitingNCT06579651
- Misdiagnosis Between Interstitial Lung Disease and Cardiac PatientsNot yet recruitingNCT06198608
- HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD PatientsNot yet recruitingNCT05999838
- Value of KL-6 in Rheumatoid Arthritis-Associated ILDRecruitingNCT05979454
- CT Quantitative Assessment of Interstitial Lung DiseaseRecruitingNCT05947422
- Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMFCompletedNCT06758947Phase 3
- Interstitial Lung Disease is a Risk Factor for Cardiovascular DiseaseCompletedNCT06539962
- Role of Lung Ultrasound in Screening for Interstitial Lung Disease in Patients With Rheumatoid ArthritisCompletedNCT06531785
- Risk Factors and Prognostic Parameters of Interstitial Lung Disease in ChildrenStatus unknownNCT06125288
- Rituxmab Versus IL-6 in Treating ILDCompletedNCT05963048Phase 2/3
- Assessment of Neuropsychiatric Function in Patients With Interstitial Lung DiseaseCompletedNCT05719233
- CXCL10 As a Biomarker Of ILD in Patients WithRAStatus unknownNCT04356066Not applicable
- Long Term Oxygen Therapy in Patients With Interstitial Lung DiseaseStatus unknownNCT04089826
- Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary FibrosisStatus unknownNCT03440489Not applicable
- The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung DiseaseCompletedNCT03396120